ࡱ> O 0?bjbj88  RWiRWi63dd''F(F(F(Z(Z(Z(8(|)DZ(/DR++,,,4~;6T6,CCCCCCC$GIbCF(6}4@466C'',,oC>>>6j'8,F(,C>6C>>:&C,.(fC,M0z%7RC CC0/D\C 'J7^'JfC'JF(fC466>66666CCM;^666/D6666'J666666666dX &:  Programme Details 1. Programme titlePharmaceutical Engineering2. Programme codeCPET453. QAA FHEQ levelMasters - 74. FacultyEngineering5. DepartmentCBE6. Other departments providing credit bearing modules for the programmeNone7. Accrediting Professional or Statutory BodyNot applicable8. Date of production/revisionDecember 2022 AwardsType of awardDuration9. Final awardMSc1 year10. Intermediate awards PG Diploma as exit awardPG Certificate as exit award Programme Codes 11. JACS code(s) Select between one and three codes from the  HYPERLINK "https://www.hesa.ac.uk/support/documentation/jacs/jacs3-principal" \h HESA website.H81212. HECoS code(s) Select between one and three codes from the  HYPERLINK "https://www.hesa.ac.uk/innovation/hecos" \h HECoS vocabulary.100144 Programme Delivery 13. Mode of study Full-time14. Mode of delivery Face to face 15. Background to the programme and subject area This programme has been developed taking into consideration the requirements of the global pharmaceutical industry and the strong infrastructure and expertise available across the Department of Chemical and Biological Engineering at the University of ߲ݴý. This Masters programme provides students with a thorough understanding of pharmaceutical engineering, combining theoretical aspects of the discipline with hands-on practical experience, which ensures that our graduates are well-equipped to enter and succeed in a wide range of career areas and to meet the challenge of working within an ever-changing discipline. In particular, the programme specialises in: the science and application of products oral drug delivery the production of medicines and new technologies Students will gain hands-on experience with high-value formulated products using our industrial-scale continuous powder processing plant, become equipped with an enhanced capability for independent learning, and carry out a novel research project. Graduates from the programme will be highly sought in the pharmaceutical industry. The knowledge and skills gained during this programme in the field of particle technology will also allow graduates to work in other sectors such as food products or detergents. 16. Programme aims The MSc in Pharmaceutical Engineering aims to:A1provide access to an engineering degree to students from a range of academic and social backgrounds;A2prepare students for a professional career in industry, education, public and commercial sectors;A3develop interpersonal skills appropriate to a professional person;A4encourage students to think for themselves, work effectively on their own initiative, and develop a social awareness;A5provide experience in conducting extended individual projects;A6develop the students ability to make technical decisions;A7provide students with an education through a firm understanding and practical knowledge in pharmaceutical engineering;A8allow students to obtain a broad knowledge and deep understanding of pharmaceutical engineering. 17. Programme learning outcomes Knowledge and understanding On successful completion of the programme, students will be able to demonstrate knowledge and understanding of:Links to Aim(s)K1the science appropriate to the discipline of pharmaceutical engineering;7K2the impact of design on pharmaceutical engineering, processing and manufacturing;6-8K3the implications of bio-engineered materials and components on pharmaceutical engineering;7-8K4the professional and ethical responsibilities including the regulatory framework and the global and social context of pharmaceutical engineering;2, 7, 8K5the operational practice of (bio)processing and integrated unit operations for producing APIs and pharmaceutical products;2, 7, 8K6the requirements for safe operation, the nature of hazards and their operation;2, 6, 7, 8K7the relevant engineering practice and its limitations and have an appreciation of likely new developments;2, 6, 7, 8K8the ability to integrate knowledge of mathematics, science, information technology, design, business context and engineering practice to solve a substantial range of pharmaceutically oriented engineering problems.4, 5, 6, 7, 8Skills and other attributes (I for Intellectual Skills, P for Practical Skills, T for Transferable Skills) On successful completion of the programme, students will be able to:I1use scientific principles: in the development of engineering solutions to practical problems; in the modelling and analysis of pharmaceutical manufacturing processes and products;5, 6, 7, 8I2undertake technical risk evaluation of pharmaceutical processes and products;6, 7, 8I3produce solutions to problems through the application of pharmaceutical engineering knowledge and understanding;7, 8I4make use of computer-based models for solving problems in pharmaceutical engineering, and be able to assess the limitations of particular cases;6, 7, 8I5assimilate data from a wide range of sources, extract that which is pertinent to an unfamiliar problem, and apply this to a particular problem;6P1make use of relevant test and measurement equipment in experimental laboratory-based research work;4, 5P2undertake practical testing of scientific hypotheses in the laboratory or through simulation, with technical analysis and critical evaluation of results;5P3apply engineering techniques taking account of industrial and commercial constraints;4, 7, 8P4effectively manage their time in the context of research project;2, 3P5understand the design methodologies, engineering and IT tools related to pharmaceutical engineering and apply and adapt them in unfamiliar situations;5, 6, 7P6research and use new methods required for novel situations and adapt to specific purposes as necessary;4, 5T1undertake manipulation sorting and presentation of data;1, 2, 3T2make use of scientific evidence-based methods in the solution of problems;2, 6, 8T3make use of general IT tools;2, 3T4work with limited or contradictory information and apply creativity and innovation to the solving of problems;2, 3T5manage time and resources and effectively communicate as a team member and demonstrate leadership skills;1, 2, 3T6understand concepts from a range of areas, and the ability to apply them effectively in technical and business decisions;1, 2, 3, 4T7integrate presentational techniques and the information to be presented for maximum impact;2, 3T8work with the minimum of supervision, being proactive in their approach to learning and be able to: be innovative in the use of a broad range of scientific principles in solving engineering problems; develop, monitor and update a plan to reflect a changing operating environment; monitor and adjust a personal programme of work on an on-going basis and can learn independently.1, 2, 3, 4 18. Learning and teaching methods The main teaching methods adopted for each learning outcome are shown below. In most cases a combination of methods is used. Emphasis is on learning by doing, in particular for developing self-directed learners. Knowledge and understanding are gained through a combination of lectures, tutorials, example classes, design classes, laboratory experience, open-ended problem solving and coursework assignments. Skills are acquired mainly through coursework and individual and group projects. The teaching will be delivered by a team of highly skilled academics with specific background in chemical engineering and pharmaceutical engineering. Guest lectures from industry/practitioners will be included. A range of learning spaces will be used, including the Diamond Pilot Plant. The teaching and learning material will be shared via Blackboard. Lectures used to transmit information, explain theories and concepts, and illustrate methods of analysis or design. Practical classes students undertake experiments in laboratory and pilot plant, and computing to gain practical skills. Tutorials and example classes to help students with their understanding and to resolve problems in their programme materials. Research project individual project contributing to novel research in pharmaceutical engineering. In most cases a combination of methods is used. Formal lectures are the principal means of imparting knowledge, and understanding is gained through a combination of tutorials, example classes, practical laboratory sessions and coursework assignments. The programme also provides a number of opportunities for personal development, including the interaction with those working in the field, during lectures and workshop sessions, and by encouraging responsibility in the decision-making process, often when confronting complex industrial scenarios. In addition to planned teaching and learning activities, students are also expected to learn through the preparation of coursework assignments and other assessment activities which generally require students to seek additional information and work on their own, or in small groups, to develop further understanding of the subject matter. 19. Assessment and feedback methods Knowledge and understanding are primarily assessed in written examinations. However further knowledge and understanding is gained through project work and assessed in written reports and oral presentations. Skills are acquired mainly through coursework and individual or group projects. Opportunities to demonstrate achievement of the learning outcomes are provided through the following assessment methods: Written examinations unseen examinations. Coursework submission designed to test knowledge and communication skills; these include design studies, computing assignments and laboratory reports. Class tests tests conducted during the main teaching periods to assess progress. Oral presentations The research projects and some taught modules include an oral presentation. Individual project reports these include intermediate and final reports for the Research Project and some taught modules. We will use a range of feedback mechanisms that we have designed and successfully utilised in the department. They include written and verbal, group and individual feedback from tutors; peer to peer feedback, self-reflection via keeping a skills journal, concept-check online quizzes and tutorials. All students have access to a Feedback Handbook available on the MSc Community on Blackboard, which describes in depth the different types of feedback provided in the Department. For each module, a Module Assessment and Feedback Form is provided at the beginning of the term on Blackboard, which clearly outlines feedback details and date for each assessment component. In addition, the Department provides an Assessment and Feedback Overview which summarises all assessment and feedback details per Programme per Semester. 20. Programme structure and student development In common with most degrees at the University of ߲ݴý, the programme of study is modular in nature allowing students a certain level of flexibility in the design of their degrees. Postgraduate taught modules offered by the Department are usually 15 credits, which is nominally equivalent to 150 hours of work by a student. Of this between 30 and 40 hours are usually contact time and the remainder directed/private study. Credits are accumulated by obtaining a mark of at least 50 in the assessment for the module. Students studying for the award of Masters are required to take modules to the value of 180 credits, comprising 6 compulsory 15-credit modules, a choice of two optional modules of 15 credits each, and a 60-credit supervised research project. The credits will be divided approximately evenly between both semesters. Students who do not successfully complete the full Masters programme are eligible for either the award of Postgraduate Diploma if they have accumulated 120 credits from the study of taught modules or the award of Postgraduate Certificate if they have accumulated 60 credits.Detailed information about the structure of programmes, regulations concerning assessment and progression and descriptions of individual modules are published in the University Calendar available online at  HYPERLINK "http://www.sheffield.ac.uk/calendar/" \h http://www.sheffield.ac.uk/calendar/. 21. Criteria for admission to the programme Detailed information regarding admission to the programme is available from: HYPERLINK "/postgraduate/taught/courses/2023/pharmaceutical-engineering-msc"Pharmaceutical Engineering MSc | 2023 | Postgraduate (sheffield.ac.uk) 22. Reference points The learning outcomes have been developed to reflect the following points of reference: Subject Benchmark Statements  HYPERLINK "https://www.qaa.ac.uk/quality-code/subject-benchmark-statements" \h https://www.qaa.ac.uk/quality-code/subject-benchmark-statements Framework for Higher Education Qualifications (2014)  HYPERLINK "https://www.qaa.ac.uk/docs/qaa/quality-code/qualifications-frameworks.pdf" \h https://www.qaa.ac.uk/docs/qaa/quality-code/qualifications-frameworks.pdf University Strategic Plan  HYPERLINK "http://www.sheffield.ac.uk/strategicplan" \h http://www.sheffield.ac.uk/strategicplan Education Strategy (2020-2025)  HYPERLINK "https://staff.sheffield.ac.uk/vision/education" \h https://staff.sheffield.ac.uk/vision/education 23. Additional information None This specification represents a concise statement about the main features of the programme and should be considered alongside other sources of information provided by the teaching department(s) and the University. In addition to programme specific information, further information about studying at ߲ݴý can be accessed via our Student Services web site at  HYPERLINK "http://www.shef.ac.uk/ssid" \h http://www.shef.ac.uk/ssid.     cpet45 ver22-23 PAGE1 Programme Specification A statement of the knowledge, understanding and skills that underpin a taught programme of study leading to an award from ߲ݴý  -.HIJ[\abcduv ) * 8 9 : X Y f g h i o p } ׹̵⫣h=TVh J>*h=TVh0+a>*h=TVh J5>*h Jh=TVh0+aB*CJaJphhlh=TVh0+aCJaJh=TVh JCJaJ h0+a>* h J5>*h0+ajh=TVUmHnHu9 .I$If^`gd=TV$d1$^`$^`a$gdl$<^`a$ IJ\cr]L$If^`gd=TV(($If^`gd=TVkd$$Ifs0[" '   0n(4d4 sapyt=TVcdvraKd$1$If^`gd=TV$If^`gd=TVkd$$Ifs0[" '   0n(4d4 sapyt=TVraMd$If^`gd=TV$If^`gd=TVkd|$$Ifs0[" '   0n(4d4 sapyt=TVraMd$If^`gd=TV$If^`gd=TVkd:$$Ifs0[" '   0n(4d4 sapyt=TVraa$If^`gd=TVkd$$Ifs0[" '   0n(4d4 sapyt=TV* 9 r]Gd$1$If^`gd=TV(($If^`gd=TVkd$$Ifs0[" '   0n(4d4 sapyt=TV9 : Y g r]Gd$1$If^`gd=TV(($If^`gd=TVkdt$$Ifs0[" '   0n(4d4 sapyt=TVg h i p ~ rdQQQ$$If^`gd=TV$d^`kd2$$Ifs0[" '   0n(4d4 sapyt=TV} ~     F G ۾ìlì$jh=TVh J6>*B*UphUh=TVh J6>*B*phUh Jjh JUh=TVh J6h=TVh0+aCJaJh=TVh JCJaJ h J5>* h0+a>*h0+ahlh0+a>*\hlh J>*\hlh@=h=TVh0+a>*h=TVh J>*h=TVh0+a>*CJaJ& TA++$d$If^`gd=TV$$If^`gd=TVkd$$IfdF~T T'  0n(    4dapyt=TV `MMMM$$If^`gd=TVkd$$IfdF~T T'   0n(    4dapyt=TV [@d$$d%d&d'd(d1$IfNOPQR^`gd=TVkd$$Ifd4F~T T'`   0n(    4daf4pyt=TV  H::$d^`kdr$$Ifd4F~T T'    0n(    4daf4pyt=TV$$If^`gd=TV  $1$If^`gd=TV$If^`gd=TV ) * ; < = C D E F G H I [ \ n o p y z { ǵ햏wsksbh J5CJaJhlCJaJhlh=TVh J6CJaJ h0+a>* h J5>* hl5>*h0+aCJaJh0+a$jh=TVh J6>*B*UphUh=TVh J6>*B*phUh Jjh JUh=TVh J6h=TVh0+aCJaJh=TVh JCJaJh@=h=TVh0+aOJPJQJ^J& = D B111$If^`gd=TVkdJ $$Ifs\y8"'FsU  0(4d4 sap(yt=TVD E F G H /$ 1$^`kd8 $$Ifs\y8"'FsU  0(4d4 sap(yt=TV$1$If^`gd=TVH \ o p z { ?kd& $$Ifs0j" ' k  0#(2 s4d4 sapyt=TV$If^`gdl$If^`gd=TV$d^` ^QB/$1$If^`gdl$<^`a$ $^`a$kd $$Ifs0j" ' k  0#(2 s4d4 sapyt=TV$If^`gd=TV no  12356 -./12 h=TVh J5CJaJh0+ah J5CJaJhlh=TVh0+aCJaJh=TVh JCJaJh0+aCJaJL oUH $^`a$jkd $$Ifd8&'0'2d4dap yt=TVx$If^`gd=TV & Fx$1$If^`gd=TVx$1$If^`gd=TV lYF$1$If^`gdl$1$If^`gd=TVskdX $$Ifs&Q'  0Q'4d4 sap yt=TV$If^`gd=TV$<^`a$taN$1$If^`gdl$1$If^`gd=TVkd$$Ifs0&I%  0Q'4d4 sapytl2taN$1$If^`gdl$1$If^`gd=TVkd$$Ifs0&I%  0Q'4d4 sapytl236taN$1$If^`gdl$1$If^`gd=TVkd$$Ifs0&I%  0Q'4d4 sapytltaN$1$If^`gdl$1$If^`gd=TVkdf$$Ifs0&I%  0Q'4d4 sapytl.taN$1$If^`gdl$1$If^`gd=TVkd.$$Ifs0&I%  0Q'4d4 sapytl./2taN$1$If^`gdl$1$If^`gd=TVkd$$Ifs0&I%  0Q'4d4 sapytltaN$1$If^`gdl$1$If^`gd=TVkd$$Ifs0&I%  0Q'4d4 sapytl  01LM!"stwxy{|pqstvwxyz|}~STVWYZ\]^ɽɽɽɽɽɽɽhlCJaJh@=h=TVh JCJaJh=TVh J5CJaJh J5CJaJh0+ahlh=TVh0+aCJaJh JJ1MtiiVAP$1$If^`gdl$1$If^`gd=TV 1$^`kd$$Ifs0&I%  0Q'4d4 sapytlww$1$If^`gd=TVukdN$$Ifs&3'  03'4d4 sap yt=TVn[E[$$1$If^`a$gdl$1$If^`gd=TVkd$$Ifs0!&!U 03'4d4 sapyt=TV"txWD.D$$1$If^`a$gdl$1$If^`gd=TVkd$$IfsF !&fxU  03'    2d4d4 sapyt=TVxy|WD.D$$1$If^`a$gdl$1$If^`gd=TVkd$$IfsF !&fxU  03'    2d4d4 sapyt=TVqyWD.D$$1$If^`a$gdl$1$If^`gd=TVkd$$IfsF !&fxU  03'    2d4d4 sapyt=TVyz}WD.D$$1$If^`a$gdl$1$If^`gd=TVkd$$IfsF !&fxU  03'    2d4d4 sapyt=TVT_WD.D$$1$If^`a$gdl$1$If^`gd=TVkd$$IfsF !&fxU  03'    2d4d4 sapyt=TV^_`bc,-qrsuv)*,-/02345689    hlhlCJaJh=TVh JCJaJh=TVh J5CJaJh@=h=TVh0+aCJaJM_`cWD.D$$1$If^`a$gdl$1$If^`gd=TVkd$$IfsF !&fxU  03'    2d4d4 sapyt=TVWD.D$$1$If^`a$gdl$1$If^`gd=TVkd$$IfsF !&fxU  03'    2d4d4 sapyt=TV-rWD/P$1$If^`gdl$1$If^`gd=TVkd$$IfsF !&fxU  03'    2d4d4 sapyt=TVrsv*5wdw$1$If^`gdl$1$If^`gd=TVukd$$Ifs&3'  03'4d4 sap yt=TV569S@-@$1$If^`gdl$1$If^`gd=TVkd$$IfsF !&fxU  03'    2d2 P4d4 sapyt=TV S@-@$1$If^`gdl$1$If^`gd=TVkd$$IfsF !&fxU  03'    2d2 P4d4 sapyt=TV   S@-@$1$If^`gdl$1$If^`gd=TVkd $$IfsF !&fxU  03'    2d2 P4d4 sapyt=TV'9:;<=?@FGHIJLMPh=TVh J5CJaJh@=hlCJaJh=TVh0+aCJaJh=TVh JCJaJh=TVhlCJaJN:<S@-@$1$If^`gdl$1$If^`gd=TVkd!$$IfsF !&fxU  03'    2d2 P4d4 sapyt=TV<=@S@*@$$1$If^`a$gdl$1$If^`gd=TVkd"$$IfsF !&fxU  03'    2d2 P4d4 sapyt=TVGIWD.D$$1$If^`a$gdl$1$If^`gd=TVkd#$$IfsF !&fxU  03'    2d4d4 sapyt=TVIJMWD.D$$1$If^`a$gdl$1$If^`gd=TVkd%$$IfsF !&fxU  03'    2d4d4 sapyt=TVWD.D$$1$If^`a$gdl$1$If^`gd=TVkd&$$IfsF !&fxU  03'    2d4d4 sapyt=TVWD.D$$1$If^`a$gdl$1$If^`gd=TVkd '$$IfsF !&fxU  03'    2d4d4 sapyt=TV S@*@$$1$If^`a$gdl$1$If^`gd=TVkd($$IfsF !&fxU  03'    2d2 P4d4 sapyt=TV    FGIJLMNOPRSjx ? @ B C D E F H I !8!9!;!!?!A!B!C!D!E!G!H!!!!!!h=TVhlCJaJhlCJaJh=TVh J5CJaJh@=h=TVh0+aCJaJh=TVh JCJaJN  GWC0$1$If^`gdld$If^`gd=TVkd )$$IfsF !&fxU  03'    2d4d4 sapyt=TVGOPS@-$1$If^`gdlkd%*$$IfsF !&fxU  03'    2d2 P4d4 sapyt=TV$1$If^`gd=TVS@-@$1$If^`gdl$1$If^`gd=TVkd3+$$IfsF !&fxU  03'    2d2 P4d4 sapyt=TV@ E S@-@$1$If^`gdl$1$If^`gd=TVkdA,$$IfsF !&fxU  03'    2d2 P4d4 sapyt=TVE F I S@-@$1$If^`gdl$1$If^`gd=TVkdO-$$IfsF !&fxU  03'    2d2 P4d4 sapyt=TV 9!D!S@-@$1$If^`gdl$1$If^`gd=TVkd].$$IfsF !&fxU  03'    2d2 P4d4 sapyt=TVD!E!H!!!S@-@$1$If^`gdl$1$If^`gd=TVkdk/$$IfsF !&fxU  03'    2d2 P4d4 sapyt=TV!!!!!!"""t"u""""#&#'#)#*#,#-#/#0#1#2#3#4#8#U#V#$V$%B%C%V%&V&&&&&'''+'M''''(((%(M(w(x()M)r)s)*M*N*h0+aB*CJaJphh J5CJaJh J5B*CJaJphh0+ahlCJaJh=TVh JCJaJh=TVh J5CJaJh@=h=TVh0+aCJaJ?!!!"S@-$1$If^`gdl$1$If^`gd=TVkdy0$$IfsF !&fxU  03'    2d2 P4d4 sapyt=TV"u""'#2#$1$If^`gd=TV & F($1$If^`gdl2#3#4#SH 1$^`kd1$$IfsF !&fxU  03'    2d2 P4d4 sapyt=TV4#V#C%&''(x(s)*iT$1$If^`gdlxx$1$If^`gdlx$1$If^`gd=TVxx$1$If^`gd=TVx$1$If^`gdl>$ @ $d%d&d'd(dNOPQR^` N*]***++++++,,,,-2-3--------.p.q.}...../$/%/?/f/////0c0r0000001(111~1112?2@2222222ȿ߳߳߳߳߳Чh0+ahlCJaJh=TVh J5CJaJh J5CJaJh0+aCJaJhlh=TVh0+aB*phh=TVh0+aCJaJh=TVh JCJaJh=TVhlCJaJ?*+++,3---q.~tt_LLLx$If^`gd=TVx$1$If^`gd=TV ^`jkd2$$IfHp&`'0`'44 Hap yt=TVxx$1$If^`gd=TVq..%//1@222\jkd3$$IfHp&`'0`'44 Hap yt=TV$If^`gd=TVxx$If^`gd=TVx$If^`gd=TV2235f7g7/jkd3$$IfHp&`'0`'44 Hap yt=TVxx$If^`gd=TVx$If^`gd=TV>$ @ $d%d&d'd(dNOPQR^`22223 33445555@5A566%6366677e7f7g7885868k8l8888888888ҿҿһvgh=TVh0+aB*CJaJph)jh=TVh J>*B*CJUaJph h=TVh J>*B*CJaJphh Jjh JUh=TVh JB*CJaJphhlh0+ahlCJaJh=TVh0+aCJaJh=TVh JCJaJh0+aB*CJaJphh J5CJaJh J5B*CJaJph(g788Ujkd84$$IfHp&`'0`'44 Hap yt=TV?xx$$d%d&d'd(dIfNOPQR^`gd=TV8889?xx$$d%d&d'd(dIfNOPQR^`gdl>$ @ $d%d&d'd(dNOPQR^`88889 9 999v9w999999999:-:.:J:K:L::::::;;;;L;ѵ}}lW}})jh=TVh J>*B*CJUaJphU h=TVh J>*B*CJaJphUh=TVh0+aCJaJh=TVh J5CJaJh=TVh J5h0+aCJaJh J5CJaJh0+ahlh=TVh0+aB*phh=TVh J>*B*phh Jjh JUh=TVh JCJaJh=TVh JB*CJaJphh0+aB*CJaJph"9999.:WC$$ @ xx$If^`gd=TV$ @ ^`>$ @ $d%d&d'd(dNOPQR^`jkd4$$IfHp&`'0`'44 Hap yt=TV.:K::;;;9<X<<x$If^`gd=TVx$If^`gdl @ $If^`gd=TV @ x$If^`gd=TVL;n;o;;;;;;;<<<7<8<9<W<X<Y<<<<<<<<<<<<<øøÎ|paRhlh0+aB*CJaJphhlhlB*CJaJphh0+aB*CJaJphh J5B*CJaJphh0+ahl)jh=TVh J>*B*CJUaJph h=TVh J>*B*CJaJphh=TVh JCJaJh=TVh0+aCJaJ)jh=TVh J>*B*CJUaJphU h=TVh J>*B*CJaJphUjh JUh J<<<<NN>$ @ $d%d&d'd(dNOPQR^`skd`5$$IfHp&`'0`'22 H44 Hap yt=TV<<<<>U=(xx$If^`gd=TV$ @ xx^`jkd6$$IfHp&`'0`'44 Hap yt=TV?xx$$d%d&d'd(dIfNOPQR^`gdl<<==>i>j>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>л|ogoh JB*phjh JB*UphhdhB*CJaJphh JB*CJaJphh0+aB*phhDjhDUh0+ahlh=TVh0+aCJaJ)jh=TVh J>*B*CJUaJph h=TVh J>*B*CJaJphh Jjh JUh=TVh JCJaJh0+aCJaJ&>>>>>>>>>>>>>~~~~t ^` d^` ^`jkd6$$IfHp&`'    0`'44 Hap yt=TV >>>>>>>7<$ 9r $d%d&d'd(dNOPQR^`a$9 9r $d%d&d'd(dNOPQR^` !^` ^`<$ 9r $d%d&d'd(dNOPQR^`a$>>>>>>>>>>>?y?z????????????ŵh J5B*CJphh0+ah J5B*CJphhDhlh Jh0+aB*phjh JB*Uphh=TVB*mHnHphu>>>>>>>?z????????? d^`d<<^`$d<^`a$$d<^`a$$d<<^`a$ !^` ^` ^`50P. A!`"`#@$% Dpn| x+cxYq]PNG  IHDR1t2IDATx^]oyEEڻBho #}2 Zx"]\no~ME wջ{^^ v),3C΋V8/Av^/QY9S8lnЌaJ3 +:vH+}s&g.%FJ̶jm3Yk3s][CL;3ؕ^kS0ۭ\l&YZSfIv+|:Lb7i;tN?*g{|{6qs ɟYh*5gЫ7;j5:9stlڞNRG3dYeܛ|$@Ԕuss߆69asqjLrWva9^͵ZoNx8g*߭2[[HNpǜKpWB|8np2c ]8Ig0rqKL* N} ]8Mb|uէR cFr;gprqodbm$wd6sB-83t|4u=#Xcv '9)'`@l}u9JLpƕKβrh1'2uԥ Δ۟K99uKq8 Ar*/gtJօӌ9GyS?>kgq k1C8yj~Z椶';:ɏ(/'2 Nw|$i&:!ڌӺp1(rzOkjzC JƢ<^,wtչ8hЎF]+䓬51 N?(rq><-Rzsy o{dG1.GSп 8ĩTŨqutAd ްi>>:7̜<ԉ7+ғG&8qgq~66冮K9b˞bX,×Va/NSFyS^HI$?ʣ<8 O1l4ϥ<>}8G;q>y]v=8Gp>&KniL xe>SNщEÉ߽5@y:CJBz@O3l y{>?t o؟˞N32pJwߐ~NSߓSs*[c :qmX/NAWNeb4>󳦰­6;ϰߟ5Erʗ&Px)01mI)srk87[Jpܧ2}kbe*z/#\#'?5N-'d)Nru1N$S}^ɹ۞@BE9oMq = _b[eD)˟H4LK)괔X9?oI?TSג'Y8gICےAӑOn+8~s^$.'r΃+ջpj)Nz{醓 D e"NA1oNlsn$ۄ)3 ,ls='ϜW'L2E/^g9o)jIӧ^݀vl_!Emo޳{qP9= m0]r =Ph|5qKd~v]&-g/9/8 Mi8Τ̜ebU_nJDf6D9 ~,KY/ u3L2KcTlu2sKMuhϑ&'n^XFx5n-|^{'I]8mp )U_c8pRI󦴴_'Q>ct-a1ǿ0yks#NSs]q|Cm K>̧"I ؤYP/qkE9|dM,}4aӂÔ9D(NA;٬&lIWS9}t$ޝG68m5ݮ'NµBHf+NKZ'윒sZӑdr⸘Sǚ^m&IwhtrpĉGy@rbo%Ω7>}47ȯE49[s'uJirlR.Nʪhn2ljJaWN.7pq:'%[^]88u '1bp1ZNS.N(Ε'uώ|S85i(z3\"Ο;7'^0q14ZgT=ҜΧy2S8 τEƘS?L\NZm8#Odh1C-|3sqJ]\6~2S8%# dU|:qx4"JL$S;L|b슱hw^]S[upV[!#0S|#5F9J=W:Ap>qξڵq.&8]M'Ksq*SstqJ:T㤯y2{ifuiOΩ8$g.nsrr;U.˼ʸX6i$8'& W[眪Ãm!ki>Oup "NgNp=VGMIq:)Nq"Nũ.pCoEɲFacN,g|go6|&'iLT9fl"}r陜ܖA'g/9F>{Fw>3FlN -N]U=@Έ0zcEIN8CɈWMBG t3<̠TU$rS#n+NnV7ȯgvog;q!Kr‹#MWsi \C1d ipC=;qi8JF"M=3iZG>;'Oqj{Y$,hq"Nn kyp/LYRq_kEGcB@0,T }ʠ7;%RCNUz%$*g#4s:2ٔt]NU>N79ңɗiw"C>z)+PSo 1=P=U8}Htmg ^ʩ gq eH9=NsirqrSu9yS2s:R~doT}Y_pVt%+'5t>b9ySrp fup[6 =2sR0AQ;gU9^Y[;֜ g Epxp9wၛ9C '`T [?ɾv3G̜V̩~3RP[Τa>sbQ=5RB#qڭ WV΀8WBt5߫%2g(3*~*ATy#ljQIg0ыvN_r$(I3xqt)q<{񳔙=86QlR-E@(D9-Sp8U^iQvN=+pM1ϪT@'ϡ~ ˀx y:cX NF'fXҟ&'VM0`X4E:DNZ+@{WoҒkcR7TN2bN:i(X*'*Z@5NmKd`מ9P RJWSym9HqFT𢆈3E59&C6yu象ʙAΩQ4k!eҜpC5 e8L͂Q(өGtqu?hT6Ɯ!qbԏp,2pZ*O;ҷ$Hs} S%.t|dLi[xh:l.a !rFHB9uĈ(_Ըj7DH8]Ɲ4ʌ8!Am?*L9 PnQƢ.N8B: O_1qX&M4+-Q,D9UDDf܇!)KT86ư`XEsS-3>rȜSUq$_V_ ]Ӌ T9LGwbwIwgW#9]tj`ԩD/Gs-[bNr K?+d *Q;RqNȡroرôaUHaLJSswZHeս+G3['NP9;+ɖr8NuE1':tD8]8v5V¡b _YCgӖ^b}['Xb pX~:pW!; F:<1oE5&YsyPut>;"C^M9LĹm۵ȗtjDP,HY8088Cd91G6C/(NݲZk opտ44NYRY UD[l/{*S7-d8,j fэu{6$U[Q68U<,NX5R uxmWSʆ)S'DaC cn{iD{;؊\}}I# Ks+ 7$W4yvw2Y`)o{UQy}yJjrZjh8[Y4mq(vVnER!)-F1RZ޺c NOCg7N >bZoo=A^ϫLYT좼{;T*=M488o-nɯSq2+4V;3N5WyUs*ueDù aaw})NI!{-60PpʥA]DdGpkWNoyMX%ؗ0Æ\p UջViGZ TxK !E">`ZIUUfߌM_ѧLXC|C8C9w՝7'fo;0eڃݴ{׏w7apq?h W&N1)ZJU}rlFS|oww3[U{73h+(lW&NϪ-4Vm^+'[AqIn#yC.6'Σ?2qea *ýc#CGm{mgL2g qy(wMxH2qJ^[svw7sK9kOjxlRun:5woӣ}ϩu(00RiGFo]2lNd߳}9Q`m {.c:qlrGK97}8RXr*$NDC[V^_AdW>61#}t L9q3)#;kBՇ Ͱz wQ:5,ipAvXe.m #n9`LŻ릺Ʋ~ʌ&9Y`VSوn]'$s_/RȨ0VlϑB3[QȌNq2pZ2u4gj&:qFQoN*Kӑ;u6~XSR,S73N'p-.[7`FU gLuAxxQ䒨N4i Q OrapG^S P(]1','lȥ]]wUȜ.HB*BgO~vCŜd-N5cppWz\LCm$1xTɌsUUʉa w+[:8VqX:TG< xBmـ禷q<)a'C0ORwo_S$HwK5asb-h%s9k܇^q;v;89oљJ'6([z?1d0,H;7TD^79U^pdɇOR5Ӧ 3`o^=0^&tc8)J{nI=*.sUSdm;kܬïw)̝nm2kZ2͛%stwco2i05ʼnZ?UhD{{U5HrERhm{+$ΝOVaw!@Kp:/L4>C99]]wd_DI NGn49*뽔cr"ΐ8+Mo8'wpY3`688mL]O6zsRK;li5Né#T] ?yxx!"u~ZO^}64۵k!GTğ龉 6rRh[;e^ I'F>C#3$^mTZש"NBs*DﴟS9IҥS%gr6攪sϜp0xfg\R+& pN"ͩzYsgMĝy׋98UC{Rt.,V%g*9UYJbUrXŪ,V%g*9UYJbUrXŪ,V%g*9UYJbUrXŪ,V%g*9UYJbUrXŪ,V@J2\0SIENDB`$$If!vh#v #v:V s  0n(5 54d4 sapyt=TV$$If!vh#v #v:V s  0n(5 54d4 sapyt=TV$$If!vh#v #v:V s  0n(5 54d4 sapyt=TV$$If!vh#v #v:V s  0n(5 54d4 sapyt=TV$$If!vh#v #v:V s  0n(5 54d4 sapyt=TV$$If!vh#v #v:V s  0n(5 54d4 sapyt=TV$$If!vh#v #v:V s  0n(5 54d4 sapyt=TV$$If!vh#v #v:V s  0n(5 54d4 sapyt=TV$$If!vh#v #v#v :V d 0n(5 55 4dapyt=TV$$If!vh#v #v#v :V d  0n(5 55 4dapyt=TV$$If!vh#v #v#v :V d4  0n(+5 55 4daf4pyt=TV$$If!vh#v #v#v :V d4  0n(+5 55 4daf4pyt=TV$$If!vh#v#vF#vs#vU:V s  0(55F5s5U4d4 sap(yt=TV$$If!vh#v#vF#vs#vU:V s  0(55F5s5U4d4 sap(yt=TV$$If!vh#v #vk:V s  0#(5 5k/ 2 s4d4 sapyt=TV$$If!vh#v #vk:V s  0#(5 5k/ 2 s4d4 sapyt=TV$$If!vh#v':V d0'5'2d4dap yt=TV$$If!vh#vQ':V s  0Q',5Q'/ 4d4 sap yt=TV$$If!vh#vI#v%:V s  0Q'5I5%/ 4d4 sapytl$$If!vh#vI#v%:V s  0Q'5I5%/ 4d4 sapytl$$If!vh#vI#v%:V s  0Q'5I5%/ 4d4 sapytl$$If!vh#vI#v%:V s  0Q'5I5%/ 4d4 sapytl$$If!vh#vI#v%:V s  0Q'5I5%/ 4d4 sapytl$$If!vh#vI#v%:V s  0Q'5I5%/ 4d4 sapytl$$If!vh#vI#v%:V s  0Q'5I5%/ 4d4 sapytl$$If!vh#vI#v%:V s  0Q'5I5%/ 4d4 sapytl$$If!vh#v3':V s  03'53'/ 4d4 sap yt=TV$$If!vh#v!#vU:V s 03',5!5U/ 4d4 sapyt=TV$$If!vh#vf#vx#vU:V s  03'5f5x5U/ / / 2d4d4 sapyt=TV$$If!vh#vf#vx#vU:V s  03'5f5x5U/ / / 2d4d4 sapyt=TV$$If!vh#vf#vx#vU:V s  03'5f5x5U/ / / 2d4d4 sapyt=TV$$If!vh#vf#vx#vU:V s  03'5f5x5U/ / / 2d4d4 sapyt=TV$$If!vh#vf#vx#vU:V s  03'5f5x5U/ / / 2d4d4 sapyt=TV$$If!vh#vf#vx#vU:V s  03'5f5x5U/ / / 2d4d4 sapyt=TV$$If!vh#vf#vx#vU:V s  03'5f5x5U/ / / 2d4d4 sapyt=TV$$If!vh#vf#vx#vU:V s  03'5f5x5U/ / / 2d4d4 sapyt=TV$$If!vh#v3':V s  03'53'/ 4d4 sap yt=TV $$If!vh#vf#vx#vU:V s  03'5f5x5U/ / / 2d2 P4d4 sapyt=TV $$If!vh#vf#vx#vU:V s  03'5f5x5U/ / / 2d2 P4d4 sapyt=TV $$If!vh#vf#vx#vU:V s  03'5f5x5U/ / / 2d2 P4d4 sapyt=TV $$If!vh#vf#vx#vU:V s  03'5f5x5U/ / / 2d2 P4d4 sapyt=TV $$If!vh#vf#vx#vU:V s  03'5f5x5U/ / / 2d2 P4d4 sapyt=TV$$If!vh#vf#vx#vU:V s  03'5f5x5U/ / / 2d4d4 sapyt=TV$$If!vh#vf#vx#vU:V s  03'5f5x5U/ / / 2d4d4 sapyt=TV$$If!vh#vf#vx#vU:V s  03'5f5x5U/ / / 2d4d4 sapyt=TV$$If!vh#vf#vx#vU:V s  03'5f5x5U/ / / 2d4d4 sapyt=TV $$If!vh#vf#vx#vU:V s  03'5f5x5U/ / / 2d2 P4d4 sapyt=TV$$If!vh#vf#vx#vU:V s  03'5f5x5U/ / / 2d4d4 sapyt=TV $$If!vh#vf#vx#vU:V s  03'5f5x5U/ / / 2d2 P4d4 sapyt=TV $$If!vh#vf#vx#vU:V s  03'5f5x5U/ / / 2d2 P4d4 sapyt=TV $$If!vh#vf#vx#vU:V s  03'5f5x5U/ / / 2d2 P4d4 sapyt=TV $$If!vh#vf#vx#vU:V s  03'5f5x5U/ / / 2d2 P4d4 sapyt=TV $$If!vh#vf#vx#vU:V s  03'5f5x5U/ / / 2d2 P4d4 sapyt=TV $$If!vh#vf#vx#vU:V s  03'5f5x5U/ / / 2d2 P4d4 sapyt=TV $$If!vh#vf#vx#vU:V s  03'5f5x5U/ / / 2d2 P4d4 sapyt=TV $$If!vh#vf#vx#vU:V s  03'5f5x5U/ / / 2d2 P4d4 sapyt=TV$$If!vh#v`':V H0`'5`'4 Hap yt=TV$$If!vh#v`':V H0`'5`'4 Hap yt=TV$$If!vh#v`':V H0`'5`'/ 4 Hap yt=TV$$If!vh#v`':V H0`',5`'/ 4 Hap yt=TV$$If!vh#v`':V H0`',5`'4 Hap yt=TV$$If!vh#v`':V H0`'5`'/ 22 H4 Hap yt=TV$$If!vh#v`':V H0`'5`'4 Hap yt=TV$$If!vh#v`':V H0`',5`'/  4 Hap yt=TV"9x666666666vvvvvvvvv666666>6666666666666666666666666666666666666666666666666hH66666666666666666666666666666666666666666666666666666666666666666p62&6FVfv2(&6FVfv&6FVfv&6FVfv&6FVfv&6FVfv&6FVfv8XV~ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@66666$OJPJQJ^J_HmH nHsH tHl`l Normal.d*$9D:D@&VDWD^`EH_HmH nHsH tH  Heading 11$d*$9D:D@&UDVDWD]^`@4*CJ EHH*OJPJQJRHdY(^J_HaJ mH nHsH tH  Heading 21$d*$9D:D@&UDVDWD]^`@4*CJEHH*OJPJQJRHdY(^J_HaJmH nHsH tH@  Heading 31$d*$9D:D@&UDVDWD]^`C4*>*CJEHH*OJPJQJRHdY(^J_HaJmH nHsH tH  Heading 41$d*$9D:D@&UDVDWD]^`C4*5CJEHH*OJPJQJRHdY(^J_HaJmH nHsH tH  Heading 51$d*$9D:D@&UDVDWD]^`;4*5EHH*OJPJQJRHdY(^J_HmH nHsH tH  Heading 61$d*$9D:D@&UDVDWD]^`C4*6CJEHH*OJPJQJRHdY(^J_HaJmH nHsH tHDA D Default Paragraph FontRi@R 0 Table Normal4 l4a (k ( 0No List > Title<$$dx*$9D:D@&UDVDWD]^`34*5CJHEHH*RHdY(_HaJHmH nHsH tHbJb Subtitle$$hP'6B*CJ0H*OJPJQJ^JaJ0phfff~~ :V4d4 s442d*$9D:D@&UDVDWD]^`4*EHH*RHdY(r#r :V4d44.d*$9D:D@&UDVDWD]^`4*EHH*RHdY(~3~ :V4d4 s442d*$9D:D@&UDVDWD]^`4*EHH*RHdY(~C~ :V4d4 s442d*$9D:D@&UDVDWD]^`4*EHH*RHdY(rSr :V4d44.d*$9D:D@&UDVDWD]^`4*EHH*RHdY(~c~ :V4d4 s442d*$9D:D@&UDVDWD]^`4*EHH*RHdY(~s~ :V4d4 s442d*$9D:D@&UDVDWD]^`4*EHH*RHdY(rr :V4 H44.d*$9D:D@&UDVDWD]^`4*EHH*RHdY(rr :V4 H44.d*$9D:D@&UDVDWD]^`4*EHH*RHdY(rr :V4 H44.d*$9D:D@&UDVDWD]^`4*EHH*RHdY(rr :V4 H44.d*$9D:D@&UDVDWD]^`4*EHH*RHdY(rr :V4 H44.d*$9D:D@&UDVDWD]^`4*EHH*RHdY(rr :V4 H44.d*$9D:D@&UDVDWD]^`4*EHH*RHdY(rr :V4 H44.d*$9D:D@&UDVDWD]^`4*EHH*RHdY(@ Header9dB#*$9D:D@&UDVDWD]^`(4*EHH*RHdY(_HmH nHsH tHB/B Header Char4*EHH*RHdY( @ Footer9!dB#*$9D:D@&UDVDWD]^`(4*EHH*RHdY(_HmH nHsH tHB/!B Footer Char4*EHH*RHdY(V' 1V Comment Reference4*CJEHH*RHdY(aJB  Comment Text.$d*$9D:D@&UDVDWD]^`(4*EHH*RHdY(_HmH nHsH tHN/QN Comment Text Char4*EHH*RHdY(jAB Comment Subject.&d*$9D:D@&UDVDWD]^`.4*5EHH*RHdY(\_HmH nHsH tHZ/qZ Comment Subject Char4*5EHH*RHdY(\JU J  Hyperlink 4*>*B*EHH*RHdY(phZV Z FollowedHyperlink 4*>*B*EHH*RHdY(phOr:: :V*4d4 s44*22 :V+4d44+:: :V,4d4 s44,:: :V-4d4 s44-22 :V.4d44.:: :V/4d4 s44/:: :V04d4 s44022 :V14 H4412#2 :V24 H442232 :V34 H4432C2 :V44 H4442S2 :V54 H4452c2 :V64 H4462s2 :V74 H447D Dl0Revision8EH_HmH nHsH tHPK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭Vj\{cp/IDg6wZ0s=Dĵw %;r,qlEآyDQ"Q,=c8B,!gxMD&铁M./SAe^QשF½|SˌDإbj|E7C<bʼNpr8fnߧFrI.{1fVԅ$21(t}kJV1/ ÚQL×07#]fVIhcMZ6/Hߏ bW`Gv Ts'BCt!LQ#JxݴyJ] C:= ċ(tRQ;^e1/-/A_Y)^6(p[_&N}njzb\->;nVb*.7p]M|MMM# ud9c47=iV7̪~㦓ødfÕ 5j z'^9J{rJЃ3Ax| FU9…i3Q/B)LʾRPx)04N O'> agYeHj*kblC=hPW!alfpX OAXl:XVZbr Zy4Sw3?WӊhPxzSq]y 77 .025} ^!N*28L;<>? *05?HPX`eiloruIc9 g  D H 2.xy_r5 <I GE D!!"2#4#*q.2g789.:<<>>>?!"#$%&'()+,-./12346789:;<=>@ABCDEFGIJKLMNOQRSTUVWYZ[\]^_abcdfghjkmnpqstvF);50k001v11K2223n333474X444i6667XXXXXXXXX$)+5!l,b$ x+cxYq]7@(    6!e!e"3"L:?PK!8[Content_Types].xmlAN0EH%N@%邴K@`dOdlyLhoDX3'AL:*/@X*eRp208J妾)G,R}Q)=HiҺ0BL):T뢸WQDY;d]6O&8* VCLj"󃒝 yJ.;[wIC_ :{IOA !>Ø4 p;fɑ3׶Vc.ӵn(&poPK!8! _rels/.relsj0 }qN/k؊c[F232zQLZ%R6zPT]( LJ[ۑ̱j,Z˫fLV:*f"N.]m@= 7LuP[i?T;GI4Ew=}3b9`5YCƵkρؖ9#ۄo~e?zrPK!Odrs/e2oDoc.xmlSێ }@7t8jW*H~#a}<9gƛi$+kZ,rJSw>R3ֈ6Ei{;AG>Wg_X' J  !뀍>l9\xO!&|)ߤ"P imm7>sX L F nJHPMgN$-hwo6˿^ІcULF~dj\ݕŊsZƉ)U__E.WXʁH  ؙd;=0ěժ)SQ91.=ʴfĸ](LtQ)$|38 ? %ADBJ*ԋ=a'-P2!1Xjr!N]2m?PK! & drs/downrev.xmlLN0HHܨMiT7$D/IxNޞ퉞Fo5;o׋ypR jo;j4|~ܤ B4dM 5bmqy#\Fphhc2)Cݢ3a$f?~t&iGspDGLG5Z4Wi5zX束޴Z@D\1su(S'ASYVkI@T'pY|APK-!8[Content_Types].xmlPK-!8! /_rels/.relsPK-!O.drs/e2oDoc.xmlPK-! & (drs/downrev.xmlPK1   FA?"image2.png#" ?B S  ?7x/t T _heading=h.gjdgxs_heading=h.30j0zll_heading=h.1fob9te_heading=h.3znysh7_heading=h.2et92p0_heading=h.tyjcwt_heading=h.3dy6vkm_heading=h.1t3h5sf_heading=h.17dp8vu_heading=h.3rdcrjnG0347 G0347*/6666666666677V ` kt !!M&X&0(5(9-A-66666666666773333333333aabbHIyystvwVWYZ\]--,-/023'IJLMjxBC;<>?AB)*,-/0N"]"''r((~)~)**@-A-..00 1 11194944444446666667aabbHIyystvwVWYZ\]--,-/023'IJLMjxBC;<>?AB)*,-/0N"]"''r((~)~)**@-A-..00 1 11194944444446666667`X&\uX^`H*OJPJQJ^J%^`H*OJ PJ QJ ^J o ^ `H*OJPJQJ^J%t ^t `H*OJPJQJ^J%D^D`H*OJ PJ QJ ^J o^`H*OJPJQJ^J%^`H*OJPJQJ^J%^`H*OJ PJ QJ ^J o^`H*OJPJQJ^J%^`>*H*%^`>*H*%p^p`>*H*%@ ^@ `>*H*%^`>*H*%^`>*H*%^`>*H*%^`>*H*%P^P`>*H*%\u`Xl@==TV0+aDdh J66@7 @Unknown G.[x Times New Roman5Symbol3. .[x Arial7..{$ Calibri7GeorgiaW,|8DengXian LightI{~ LightC.,.{$ Calibri Light? |8DengXianI{~[Noto Sans SymbolsCalibri?= .Cx Courier NewA$BCambria Math"qh6g6g*.cE#/d!`@206L7CQ@P $P0+a2! xx3>R Claire AllisonClaire Allison  Oh+'0d   , 8DLT\Claire AllisonNormalClaire Allison2Microsoft Office Word@F#@&z@&z*. ՜.+,D՜.+,, hp|  c6  Title 8@ _PID_HLINKSA6`=http://www.shef.ac.uk/ssid8)/https://staff.sheffield.ac.uk/vision/educationD )http://www.sheffield.ac.uk/strategicplanBJhttps://www.qaa.ac.uk/docs/qaa/quality-code/qualifications-frameworks.pdf:| @https://www.qaa.ac.uk/quality-code/subject-benchmark-statementsz  \https://www.sheffield.ac.uk/postgraduate/taught/courses/2023/pharmaceutical-engineering-msc^Q%http://www.sheffield.ac.uk/calendar/ '(https://www.hesa.ac.uk/innovation/hecos Bhttps://www.hesa.ac.uk/support/documentation/jacs/jacs3-principal  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~Root Entry F@0zData )71Table;JWordDocument  SummaryInformation(DocumentSummaryInformation8MsoDataStore0zM0zERERETQSNBISNBIEQSNA==2 0z&0zItem  +PropertiesRNEGLWZQ==2 0zM0zItem  !Properties 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    F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q